Division of Cardiovascular Medicine, The Mount Sinai Health System, 1190 5th Avenue, 1st Floor, New York, NY 10029, USA.
Department of Biofunction Research, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan.
Cardiol Clin. 2023 Nov;41(4):491-499. doi: 10.1016/j.ccl.2023.06.006. Epub 2023 Jun 15.
Minoritized racial and ethnic groups have the highest incidence, prevalence, and hospitalization rate for heart failure. Despite improvement in medical therapies and overall survival, the morbidity and mortality of these groups remain elevated. The reasons for this disparity are multifactorial, including social determinant of health (SDOH) such as access to care, bias, and structural racism. These same factors contributed to higher rates of COVID-19 infection among minoritized racial and ethnic groups. In this review, we aim to explore the lessons learned from the COVID-19 pandemic and its interconnection between heart failure and SDOH. The pandemic presents a window of opportunity for achieving greater equity in the health care of all vulnerable populations.
少数族裔群体的心力衰竭发病率、患病率和住院率最高。尽管医疗技术和整体存活率有所提高,但这些群体的发病率和死亡率仍然居高不下。造成这种差异的原因是多方面的,包括健康的社会决定因素(如获得医疗保健的机会、偏见和结构性种族主义)。这些相同的因素导致少数族裔群体 COVID-19 感染率更高。在这篇综述中,我们旨在探讨从 COVID-19 大流行中吸取的经验教训及其与心力衰竭和社会决定因素之间的联系。大流行为所有弱势群体的医疗保健实现更大公平提供了一个机会之窗。